GlobeNewswire 30/10/2025 Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development
GlobeNewswire 30/10/2025 Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 29/10/2025 Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Pha...
GlobeNewswire 29/10/2025 Immutep Quarterly Activities Report Q1 FY26
GlobeNewswire 28/10/2025 RNA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Avidity Biosciences, Inc. is ...
TeleTrader 28/10/2025 Europe closes mixed ahead of ECB, Fed decisions
GlobeNewswire 28/10/2025 Novartis completes acquisition of Tourmaline Bio
GlobeNewswire 28/10/2025 Sevaro Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups
GlobeNewswire 28/10/2025 Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Eff...
GlobeNewswire 28/10/2025 Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer
GlobeNewswire 28/10/2025 Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding the diversity of TP...
TeleTrader 28/10/2025 Europe mostly down at open amid data
TeleTrader 28/10/2025 Europe in premarket as more earnings pour in
GlobeNewswire 28/10/2025 Novartis announces expiration of Tourmaline Bio tender offer 
TeleTrader 28/10/2025 Novartis posts Q3 sales of $13.9 billion, up by 7%
GlobeNewswire 28/10/2025 Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; ...
GlobeNewswire 27/10/2025 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential U...
GlobeNewswire 27/10/2025 CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis® and Beovu®
TeleTrader 27/10/2025 Novartis CEO defends Avidity deal
GlobeNewswire 27/10/2025 Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via a novel mechanism wi...
GlobeNewswire 26/10/2025 RNA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AVIDITY BIOSCIENCES, INC. IS ...
TeleTrader 26/10/2025 Novartis to buy Avidity Biosciences for $12B
GlobeNewswire 26/10/2025 Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its ...
GlobeNewswire 25/10/2025 Novartis showcases significant immunology advancements in ACR congress with new data in complex auto...
GlobeNewswire 24/10/2025 Evolving Treatment Landscape for Chronic Spontaneous Urticaria Highlights Significant Unmet Needs an...